CAD and cancer: Notably, we observed CAD-Asp1371 mutations in GC tissues from human patients; the mutation abundance accounts for approximately 15% in patients who failed neoadjuvant or adjuvant chemotherapy, potentially explaining the absence of CAD D1371 mutation in the Catalogue of Somatic Mutations in Cancer (COSMIC) database.